About Contact Us Careers
Sign In

Clinical Trial Packaging Market Size & Share, by Type (Bags & Pouches, Bottles, Vials & Ampoules, Syringes, Blisters), Material (Corrugated Fiber, Glass, Plastic, Metal, Paper, Plastic), End-user (Research Laboratories, Drug Manufacturing Facilities) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 4513
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Clinical Trial Packaging Market size was over USD 3.65 billion in 2024 and is projected to cross USD 12.87 billion by the end of 2037, witnessing more than 10.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of clinical trial packaging is estimated at USD 3.95 billion.

The growth of the market can primarily be ascribed to the convenient availability and utilization of blisters in medicine packaging. As of 2019, approximately 18 to 20 % of pharmaceutical packaging was fulfilled by blister packs.

Global clinical trial packaging market trends such as, mounting spending on pharmaceuticals R&D and rising disposable income of countries are projected to influence the growth of the market positively over the forecast period. For instance, in 2020, the spending on pharma R&D across the globe was estimated to be nearly USD 200 billion while as of 2022, approximately 100,000 clinical studies were registered solely in the USA. Moreover, ongoing development in medical technology is further estimated to propel the growth of the market over the forecast period. In 2022, the medical technology industry was forecasted to generate a revenue of about USD 375 billion. Hence, such factors are estimated to hike the growth of the market during the forecast period.  

Get more information on this report: Request Free Sample PDF

Clinical Trial Packaging Sector: Growth Drivers and Challenges

Growth Drivers

  • Skyrocketing Development of Medical Drugs - It was observed that in 2021, the total spending on drugs in the USA was estimated to be approximately USD 2 billion while the number of drugs under the R&D pipeline was anticipated to be about 20,000.
  • Medical drug is another term used in the place of medicine which is developed in laboratories with different sorts of chemicals and compounds. The research on medical drugs never stops and in modern times, governments of multiple countries are more inclined to invest in drug development to flourish the healthcare infrastructure and provide cures for many untreatable diseases such as, cancer, dementia, neurological, and Alzheimer’s diseases. After the successful clinical trial, medicines are exported across countries boosting the demand for high-quality packaging.
  • Growing Utilization and Production of Corrugated Board - As of 2020, approximately 150 million tons of corrugated board were produced across the globe.
  • Rising Export and Import of Syringes - In 2021, the total volume generated by the syringe export in the United Kingdom was estimated to be nearly 90,000 U.S. dollars.
  • Booming Demand for Vaccination Worldwide - The percentage of fully vaccinated people in 2022 by country was estimated to be in UAE (100%), Maldives (100%), Cambodia (90%), Qatar (100%), Bhutan (85%), and others.

Challenges

  • Lack of Requisite Materials and Workforce
  • Requirement for Higher Initial Investment
  • Disrupted Supply-Chain due to COVOD-19

Clinical Trial Packaging Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

10.1%

Base Year Market Size (2024)

USD 3.65 billion

Forecast Year Market Size (2037)

USD 12.87 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Our in-depth analysis of the global market includes the following segments:

       By Type
  • Bags & Pouches
  • Bottles
  • Vials & Ampoules
  • Syringes, Blisters
  • Others

      By Material
  • Corrugated Fiber
  • Glass
  • Plastic
  • Metal
  • Paper
  • Plastic
  • Others

      By End-User
  • Research Laboratories
  • Drug Manufacturing Facilities

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Clinical Trial Packaging Industry - Regional Synopsis

Regionally, the global clinical trial packaging market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America region is projected to hold the largest market share by the end of 2037. The growth of the market in the region can be accounted to the growing R&D in the healthcare sector and the presence of the major key players. It was noticed that in 2022, approximately 24,000 diagnostic and medical laboratories were functioning in the United States alone. Hence, all these factors are anticipated to fuel the growth of the market in the region during the forecast period.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Clinical Trial Packaging Landscape

    • XERIMIS INC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Almac Group
    • WuXi AppTec Co., Ltd.
    • WestRock Company
    • 3M Company
    • Sentry BioPharma Services, Inc.
    • Bilcare Ltd.
    • Sharp Packaging Services, LLC
    • Corden Pharma GmbH
    • Parexel International Corporation

In the News

  • WestRock Company to make an announcement about its acquisition of HP PageWide T1190 Press. The acquisition took place to expand the company’s portfolio of unmatched corrugated printing capabilities. Additionally, WestRoack Company also offers single-source solutions to its customer for enhanced and high-quality graphics.

  • WuXi AppTec Co., Ltd. to establish a new facility for new sterile lipid nanoparticle formulation in its Wuxi city campus. The facility will fulfill the demand for complex injection dosage forms and deliver better medicines to patients with the help of fast-growing parenteral formulation capabilities.

Author Credits:  Abhishek Anil


  • Report ID: 4513
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of clinical trial packaging is estimated at USD 3.95 billion.

The clinical trial packaging market size was over USD 3.65 billion in 2024 and is projected to cross USD 12.87 billion by the end of 2037, witnessing more than 10.1% CAGR during the forecast period i.e., between 2025-2037. Skyrocketing development of medical drugs will drive the market growth.

North America industry is expected to dominate largest revenue share by 2037, due to growing R&D in the healthcare sector along with presence of the major key players in the region.

The major players in the market include XERIMIS INC, Almac Group, WuXi AppTec Co., Ltd., WestRock Company, 3M Company, Sentry BioPharma Services, Inc., Bilcare Ltd., Sharp Packaging Services, LLC, Corden Pharma GmbH, Parexel International Corporation.
Clinical Trial Packaging Market Report Scope

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample